Bill seeks to expand consumer choices

May 24, 2017

On a vote of 143-5, the House has approved legislation regarding biological drug products. House Bill 7118 authorizes a pharmacist to offer a substitute biological product if the substitute is interchangeable and not prohibited by the prescribing practitioner. It generally extends the existing requirements that allow substitution of a brand name drug for the generic equivalent. The Senate will now consider the legislation.